Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, $5 finally hit or at least close enough. At this level this is definitely a buy but gonna take a lot of patience maybe couple years to really see it move up…
See if $10 level holds. MC could drift upward later this year towards $1B area as company is similar to ETNB…
May hit $5 level this month…
Revance will need at least $100M/q in revenue to see a significant jump in share price. Meanwhile, $5/share is the likely path near term…
$5 near term, $300 long term…
Company needs to issue 40M shares at $2/sh. This would raise $80M, which would be enough to get through mid 2025…
Thanks for the breakdown!
From a stick-price perspective, I still think RVNC will test $5 but eventually has a chance to hit $300 in the 2030 time frame…
From the Wall Street Journal article it seems Daxi is at least somewhat better than Botox, so to me, that means if the price is equal to Botox patients will eventually use Daxxify in the long run…
More dilution coming via ATM. Would not begin or add to a position until at least sub $5. Mgmt to give revenue guidance in March, 2024. The company appears to be running 2 years behind Cowan projections. $300/sh buyout potential could be delayed until 2032…
Wow, instead of having a chance to go to $9, this stock has more of a chance to hit $1 by 2024. Oh well, I will just keep averaging down and sell when it eventually hits $5 again. Unfortunately that might not take place until 2025 or even 2026…
$5/sh possible over the next year. $300/sh possible by 2030 on a buyout…
PT $300 in 2030…
Ultimately sales will dictate how Daxxify is performing compared to Botox. The next few quarters will be critical for the company to regain momentum…
The reality is - Daxxify will gain at least 50% of market share from Botox for cosmetic and 100% of market for therapeutic use over time…
Is this a $300 stock in 2030?
$10 possible here…
$9 possible by 2024…
$7 possible here near term…
Only time insiders bought significantly was when price dipped below $15. Company should be cash flow positive in Q4 2024…
$20 upper range possible...
Marley brand worth billions???
Back to $25/$26 at some stage...
$10’s soon...
Menlo Crashes On Failed Phase 2 Atopic Dermatitis Study, A Great Buying Opportunity? $MNLOhttp://www.seekingalpha.com/article/4163142
Resistance at $10, then $11.30...
Maybe $7-$8 this week...
Wait for $.75...
Could eventually go under $.50
$.90’s soon...
Selling momentum
Expecting under $1 open next week...
$.90 soon...
Will $2 hold???
Insider buying
Doesn’t look good out there..
Could break $4 tomorrow
$35/36 good starting position- may have to avg down to mid $20’s...